Dual action of isoprenols from herbal medicines on both PPARgamma and PPARalpha in 3T3-L1 adipocytes and HepG2 hepatocytes (Q40739285)

23 September 2017

Dual action of isoprenols from herbal medicines on both PPARgamma and PPARalpha in 3T3-L1 adipocytes and HepG2 hepatocytes (English)

1 reference

23 September 2017

1 reference

3

Teruo Kawada

1 reference

23 September 2017

Nobuyuki Takahashi

1

1 reference

23 September 2017

Nobuyuki Takahashi

2

1 reference

23 September 2017

Tsuyoshi Goto

4

1 reference

23 September 2017

Takayuki Yamamoto

5

1 reference

23 September 2017

Aki Taimatsu

6

1 reference

23 September 2017

Naoko Matsui

7

1 reference

23 September 2017

Kazuhiro Kimura

8

1 reference

23 September 2017

Masayuki Saito

9

1 reference

23 September 2017

Masashi Hosokawa

10

1 reference

23 September 2017

Kazuo Miyashita

11

1 reference

23 September 2017

Tohru Fushiki

12

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

23 September 2017

1 reference

23 September 2017

514

1 reference

23 September 2017

315-322

1 reference

23 September 2017

2-3

1 reference

Impact of lemongrass oil, an essential oil, on serum cholesterol

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Farnesol Inhibits L-type Ca2+Channels in Vascular Smooth Muscle Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Roles of PPARs in health and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Peroxisome proliferator-activated receptor delta (PPARdelta )-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

PPAR gamma is required for placental, cardiac, and adipose tissue development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Mechanism of action of fibrates on lipid and lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

The antidiabetic agent thiazolidinedione stimulates the interaction between PPAR gamma and CBP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Counteraction of retinoic acid and 1,25-dihydroxyvitamin D3 on up-regulation of adipocyte differentiation with PPARgamma ligand, an antidiabetic thiazolidinedione, in 3T3-L1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Binding of prostaglandins to human PPARgamma: tool assessment and new natural ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Peroxisome proliferator-activated receptor gamma and metabolic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

Carotenoids and retinoids as suppressors on adipocyte differentiation via nuclear receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2902390-6

10.1016/S0014-5793(02)02390-6

7 January 2021

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fdp6aohvhvax3kvceaqecdniae

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_fdp6aohvhvax3kvceaqecdniae

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fdp6aohvhvax3kvceaqecdniae

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/fdp6aohvhvax3kvceaqecdniae